MSRB3
Methionine-R-sulfoxide reductase B3
Also known as: DFNB74, DKFZp686C1178, FLJ36866, MSRB3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IXL7
- Gene
- MSRB3
- Ensembl
- ENSG00000174099
- Chromosome
- 12
- Canonical length
- 192 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
The protein encoded by this gene catalyzes the reduction of methionine sulfoxide to methionine. This enzyme acts as a monomer and requires zinc as a cofactor. Several transcript variants encoding two different isoforms have been found for this gene. One of the isoforms localizes to mitochondria while the other localizes to endoplasmic reticula. [provided by RefSeq, Jul 2010]
Canonical amino-acid sequenceUniProt
192 residues, UniProt reviewed canonical sequence.
>Q8IXL7|MSRB3
1 MSPRRTLPRP LSLCLSLCLC LCLAAALGSA QSGSCRDKKN CKVVFSQQEL RKRLTPLQYH
61 VTQEKGTESA FEGEYTHHKD PGIYKCVVCG TPLFKSETKF DSGSGWPSFH DVINSEAITF
121 TDDFSYGMHR VETSCSQCGA HLGHIFDDGP RPTGKRYCIN SAALSFTPAD SSGTAEGGSG
181 VASPAQADKA ELLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MSRB3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 169 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 169 nTPM
- smooth muscle: 116 nTPM
- colon: 101 nTPM
- skeletal muscle: 97 nTPM
- seminal vesicle: 97 nTPM
- heart muscle: 85 nTPM
Single-cell type
- hematopoietic stem cells: 826 nCPM
- vascular smooth muscle cells: 616 nCPM
- smooth muscle cells: 524 nCPM
- myonuclei: 517 nCPM
- salivary myoepithelial cells: 449 nCPM
- neutrophil progenitors: 392 nCPM
Immune cell
- eosinophil: 42 nTPM
- basophil: 15 nTPM
- plasmacytoid DC: 11 nTPM
- NK-cell: 8.2 nTPM
- neutrophil: 6.8 nTPM
- total PBMC: 1.4 nTPM
Brain region
- choroid plexus: 33 nTPM
- hypothalamus: 33 nTPM
- thalamus: 33 nTPM
- medulla oblongata: 27 nTPM
- midbrain: 26 nTPM
- spinal cord: 25 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MSRB3.
Disease | AllUniProt
Conditions MSRB3 is implicated in, by any mechanism.
- Deafness, autosomal recessive, 74 (DFNB74) MIM:613718
Disease | GeneticClinVar
10 pathogenic / likely-pathogenic of 127 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autosomal recessive nonsyndromic hearing loss 74
- Hearing loss, autosomal recessive
- Rare genetic deafness
- Hearing loss
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.16
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.31
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- L-methionine-(R)-S-oxide reductase activity
- peptide-methionine (R)-S-oxide reductase activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MSRB3 as an antibody target. Whether an autoantibody or antibody against MSRB3 could matter depends on whether native MSRB3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MSRB3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MSRB3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...